Ultra-heavy cannabis users with no other substance use showed elevated psychotic traits and cognitive deficits

In a unique population of exclusive, ultra-heavy cannabis users averaging over 30,000 lifetime exposures, researchers found significantly higher schizotypal scores and worse cognitive performance compared to matched non-using controls.

D'Souza, Deepak Cyril et al.·Psychological medicine·2020·Moderate EvidenceCross-Sectional
RTHC-02490Cross SectionalModerate Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
N=15

What This Study Found

Cases averaged 30,000+ lifetime cannabis exposures with no other substance use. They had significantly higher SPQ scores (24 vs. 13, p = 0.031) and lower composite cognitive scores (-0.23 vs. +0.28, p = 0.03) than controls. Moderate to large effect sizes were noted for attention, psychomotor speed, working memory, cognitive flexibility, visuospatial processing, and verbal memory. A subsample showed worse scores than their own non-using siblings.

Key Numbers

15 cases, 12 controls. Mean SPQ: 24 vs. 13 (p = 0.031). Composite cognition: -0.23 vs. +0.28 (p = 0.03). Cases averaged 30,000+ lifetime cannabis exposures. Moderate to large effect sizes across cognitive domains.

How They Did This

Cross-sectional study of 15 ultra-heavy cannabis users from a unique cultural group where cannabis use is central but all other substances (tobacco, alcohol) are forbidden. Compared with 12 matched controls from the same community. Schizotypal Personality Questionnaire and culture-neutral cognitive battery administered.

Why This Research Matters

This study addresses a major limitation in cannabis research: confounding from other substance use. By studying a population that exclusively uses cannabis, the findings are more directly attributable to cannabis itself.

The Bigger Picture

While most cannabis studies struggle with polysubstance confounding, this unique population provides unusually clean evidence that heavy, chronic, early-onset cannabis use is associated with psychosis-relevant traits and cognitive deficits.

What This Study Doesn't Tell Us

Very small sample; cross-sectional design; the unique cultural context may limit generalizability; cannot determine whether pre-existing differences led to cannabis use patterns.

Questions This Raises

  • ?Would similar effects be found at lower levels of cannabis exposure?
  • ?Is the cultural context protective in ways that could be studied?

Trust & Context

Key Stat:
30,000+ lifetime cannabis exposures; no other substance use; significantly elevated psychotic traits
Evidence Grade:
Very small but uniquely controlled sample addressing the critical confound of polysubstance use.
Study Age:
Published in 2020.
Original Title:
Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.
Published In:
Psychological medicine, 50(14), 2452-2459 (2020)
Database ID:
RTHC-02490

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

What makes this study special?

Most cannabis studies cannot separate cannabis effects from other substance use. This study examined a cultural group where cannabis is central to daily life but all other substances (including tobacco and alcohol) are forbidden, providing unusually clean evidence.

How heavy was their cannabis use?

The 15 cases averaged over 30,000 lifetime cannabis exposures, beginning early in life. This is far heavier than typical study populations and represents an extreme end of the use spectrum.

Read More on RethinkTHC

Cite This Study

RTHC-02490·https://rethinkthc.com/research/RTHC-02490

APA

D'Souza, Deepak Cyril; Ganesh, Suhas; Cortes-Briones, Jose; Campbell, Michael H; Emmanuel, Maisha K. (2020). Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.. Psychological medicine, 50(14), 2452-2459. https://doi.org/10.1017/S0033291719002721

MLA

D'Souza, Deepak Cyril, et al. "Characterizing psychosis-relevant phenomena and cognitive function in a unique population with isolated, chronic and very heavy cannabis exposure.." Psychological medicine, 2020. https://doi.org/10.1017/S0033291719002721

RethinkTHC

RethinkTHC Research Database. "Characterizing psychosis-relevant phenomena and cognitive fu..." RTHC-02490. Retrieved from https://rethinkthc.com/research/d-souza-2020-characterizing-psychosisrelevant-phenomena-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.